Immune checkpoint inhibitors and tyrosine kinase inhibitors in patients with advanced hepatocellular carcinoma: Does the sequence matter?

Autor: Ng, Kennedy Yao Yi, Wong, Lawrence Wen Jun, Ang, Andrea Jing Shi, Lee, Ailica Wan Xin, Tay, Desiree Shu Hui, Tan, Jack Jie En, Tan, Sze Huey, Choo, Su Pin, Tai, David Wai‐Meng, Lee, Joycelyn Jie Xin

Publikováno v: Asia Pacific Journal of Clinical Oncology; Jun2023, Vol. 19 Issue 3, p312-319, 8p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Immune checkpoint inhibitors and tyrosine kinase inhibitors in patients with advanced hepatocellular carcinoma: Does the sequence matter?

Autor: Ng KYY; Division of Medical Oncology, National Cancer Centre Singapore, Singapore., Wong LWJ; Division of Medical Oncology, National Cancer Centre Singapore, Singapore., Ang AJS; Division of Medical Oncology, National Cancer Centre Singapore, Singapore., Lee AWX; Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Tay DSH; Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Tan JJE; Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Tan SH; Division of Clinical Trials and Epidemiological Sciences, National Cancer Centre Singapore, Singapore.; Oncology Academic Programme, Duke-NUS Medical School, Singapore., Choo SP; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.; Curie Oncology, Singapore., Tai DW; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.; Oncology Academic Programme, Duke-NUS Medical School, Singapore., Lee JJX; Division of Medical Oncology, National Cancer Centre Singapore, Singapore.; Oncology Academic Programme, Duke-NUS Medical School, Singapore.

Publikováno v: Asia-Pacific journal of clinical oncology [Asia Pac J Clin Oncol] 2023 Jun; Vol. 19 (3), pp. 312-319. Date of Electronic Publication: 2022 Aug 10.